Pfizer Inc. (PFE)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 10:29AM EDT. Market open.
| Previous close | 28.20 |
| Open | 28.34 |
| Bid | 28.41 x 3100 |
| Ask | 28.42 x 3000 |
| Day's range | 28.24 - 28.70 |
| 52-week range | 25.20 - 40.37 |
| Volume | |
| Avg. volume | 41,607,636 |
| Market cap | 162.292B |
| Beta (5Y monthly) | 0.58 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.05 |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | 1.68 (5.96%) |
| Ex-dividend date | 09 May 2024 |
| 1y target est | 29.12 |
Business WirePfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression
NEW YORK, May 31, 2024--Pfizer Inc. (NYSE: PFE) today announced longer-term follow-up results from the Phase 3 CROWN trial evaluating LORBRENA® (lorlatinib, a third-generation ALK inhibitor, available in Europe under the brand name LORVIQUA®) versus XALKORI® (crizotinib) in people with previously untreated, anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). After five years of median follow-up, median progression-free survival (PFS) based on investigator asses
Investor's Business DailyThe U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
Moderna stock seesawed Thursday after confirming the U.S. government is nearing a deal to fund its pandemic bird flu vaccine.
Investor's Business DailyPfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Pfizer stock is now above its 50-day line on better-than-expected first-quarter sales. Is PFE stock a buy now?
© 2024 Yahoo. All rights reserved.